from Reuters: Health News https://ift.tt/2uLsOlB
Health Canada plans to suspend Allergan's breast implant license
Health Canada plans to suspend the license for Allergan Plc's Biocell breast implant due to the risk of a rare cancer linked to such implants, the regulator said in a notice to the Botox-maker on Thursday.
from Reuters: Health News https://ift.tt/2uLsOlB
from Reuters: Health News https://ift.tt/2uLsOlB
Subscribe to:
Post Comments (Atom)
-
The German cabinet will hold a secret session on Wednesday to discuss safeguard measures regarding the possible participation of China's...
-
Stocks poised for another day of gains Equity markets look to add to the gains from the prior session as investor concerns about the fu...
-
By LIAM STACK from NYT Magazine https://ift.tt/2FNPp6k
No comments:
Post a Comment